FATE THERAPEUTICS INC (FATE) Operating margin 2016–2025
FATE THERAPEUTICS INC (FATE) operating margin by fiscal year — reported operating income divided by reported revenue.
-2222.4%FY2025 · since FY2016: -726.1% → -2222.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2222.4% | -679.8 pp |
| FY2024 | -1542.6% | -1242.8 pp |
| FY2023 | -299.9% | +20.4 pp |
| FY2022 | -320.2% | +68.3 pp |
| FY2021 | -388.6% | +18.9 pp |
| FY2020 | -407.5% | +535.7 pp |
| FY2019 | -943.1% | +472.3 pp |
| FY2018 | -1415.4% | -389.5 pp |
| FY2017 | -1025.9% | -299.8 pp |
| FY2016 | -726.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE RevenueFATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →